Research & Development

Is a Molecular Gatekeeper the Next Cancer Target?
Research & Development Is a Molecular Gatekeeper the Next Cancer Target?

For decades, the cellular machinery responsible for building life’s essential proteins was viewed as a simple, unguided assembly line, but new evidence suggests a sophisticated manager has been overseeing the entire operation all along. This molecular coordinator, known as the nascent

Approved Drug Reverses Key Sign of Alzheimer's Damage
Research & Development Approved Drug Reverses Key Sign of Alzheimer's Damage

In the relentless battle against neurodegenerative diseases, a new and unexpected ally has emerged from a corner of medicine previously focused on cancer treatment and immune system support. A comprehensive new study has revealed that an FDA-approved drug, used safely for over three decades,

Could a Twist in DNA Be Key to Cancer Therapy?
Research & Development Could a Twist in DNA Be Key to Cancer Therapy?

Within the microscopic confines of a cell's nucleus, the two-meter-long strand of human DNA is not merely a static blueprint but a dynamic, physically active entity, a revelation that is reshaping our fundamental understanding of biology. Recent research has uncovered a previously unappreciated

Awareness Campaign Leads to Early Cancer Diagnosis in Nigeria
Research & Development Awareness Campaign Leads to Early Cancer Diagnosis in Nigeria

In the complex landscape of global health, few challenges are as daunting as tackling late-stage cancer diagnoses in regions with limited resources. Ivan Kairatov, a biopharma expert whose work sits at the intersection of technological innovation and public health, has been at the forefront of a

New Funding Reshapes the Fight Against Cancer
Research & Development New Funding Reshapes the Fight Against Cancer

A fundamental transformation is underway in the landscape of cancer research funding, signaling a deliberate pivot from broad, generalized support to a highly strategic, multi-pronged investment in the future of oncology. This sophisticated approach is built upon a clear consensus that progress

System, Not Patients, Blocks Access to Genetic Care
Research & Development System, Not Patients, Blocks Access to Genetic Care

As a biopharma expert deeply invested in the intersection of technology and healthcare delivery, I’ve spent my career focused on innovation in research and development. My latest work, however, has shifted focus to a more fundamental problem: the stubborn gaps in who gets to benefit from modern

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later